PELTHOS THERAPEUTICS INC (PTHS) Stock Analyst Ratings
USA - NYSEARCA:PTHS - US1711262048 - Common Stock
29 USD
+0.71 (+2.51%)
ChartMill assigns a Buy % Consensus number of 85% to PTHS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 67.32. This target is 132.14% above the current price.
PTHS was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about PTHS.
In the previous month the buy percentage consensus was at a similar level.
PTHS was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-14 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2025-09-02 | Oppenheimer | Initiate | Outperform |
PELTHOS THERAPEUTICS INC / PTHS FAQ
What is the average price target for PELTHOS THERAPEUTICS INC (PTHS) stock?
8 analysts have analysed PTHS and the average price target is 67.32 USD. This implies a price increase of 132.14% is expected in the next year compared to the current price of 29.
Can you provide the consensus rating for PELTHOS THERAPEUTICS INC stock?
The consensus rating for PELTHOS THERAPEUTICS INC (PTHS) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.